PERIPROCEDURAL MYOCARDIAL DAMAGE
Percutaneous coronary intervention (PCI), as a method of myocardial revascularisation, is widely and effectively used for the treatment of coronary heart disease (CHD), with immediate success rates of >90%. Depending on the diagnostic criteria, 5–30% of these patients could develop the signs...
Saved in:
| Main Author: | S. A. Akinina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2013-02-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/127 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COMPARATIVE PROGNOSTIC VALUE OF CREATINE PHOSPHOKINASE MB AND TROPONIN T IN THE DIAGNOSTICS OF PERIPROCEDURAL MYOCARDIAL DAMAGE
by: S. A. Akinina
Published: (2012-06-01) -
Non-Dipping Pattern Is Associated with Periprocedural Myocardial Infarction in Hypertensive Patients Undergoing Elective Percutaneous Coronary Intervention
by: Ozkan Bekler, et al.
Published: (2025-04-01) -
Frequency and Prognostic Value of Acute Periprocedural Myocardial Injury in Elective Percutaneous Coronary Interventions
by: E. O. Nalesnik, et al.
Published: (2024-02-01) -
Evaluating the effects of empagliflozin in preventing myocardial injury in patients undergoing percutaneous coronary intervention: A double-blind, randomized clinical trial
by: Hossein Behzad, et al.
Published: (2024-06-01) -
Silent periprocedural myocardial infarction during non-cardiac surgery: a case report
by: E. V. Ivanova, et al.
Published: (2025-03-01)